LC8+3*J_?-R:G<#7WK]0>!-VI6|$>&J07!N=427
SYSTEM PROCESSING...
LC8+3*J_?-R:G<#7WK]0>!-VI6|$>&J07!N=427
SYSTEM PROCESSING...
Posted: 2025-06-03 03:28:47 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-06-03 03:30:14 UTC
Verified By
Rollup News
The FDA approved Moderna's new COVID shot, mNEXSPIKE®, but it was tested against another COVID shot (Spikevax®) instead of a placebo due to "ethics," raising concerns about measuring absolute safety and risk of adverse events. The author argues this is a regulatory sleight of hand that prevents real answers about the vaccine's harm compared to doing nothing.
FDA approval of Moderna's mNEXSPIKE® vaccine.
Testing against another COVID shot (Spikevax®) instead of a placebo.
Concerns about measuring absolute safety and risk of adverse events.
Regulatory sleight of hand and ethical concerns.
Lack of comparison to doing nothing.
Lack of placebo testing in trials.
Difficulty in measuring absolute safety and risk.
Regulatory ethics in vaccine approvals.
Potential masking of harm due to comparator vaccine side effects.
Incomplete and rushed trials.